FDA — authorised 21 January 2021
- Application: NDA212887
- Marketing authorisation holder: VIIV HLTHCARE
- Local brand name: VOCABRIA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Cabotegravir Tablets, for oral use. in United States
FDA authorised Cabotegravir Tablets, for oral use. on 21 January 2021
Marketing authorisation
Other Infectious Disease / Virology approved in United States
Frequently asked questions
Is Cabotegravir Tablets, for oral use. approved in United States?
Yes. FDA authorised it on 21 January 2021.
Who is the marketing authorisation holder for Cabotegravir Tablets, for oral use. in United States?
VIIV HLTHCARE holds the US marketing authorisation.